MBX Biosciences, Inc. Common Stock

NASDAQ:MBX

Biotechnology

Healthcare
$53.42 -1.54%

-$0.64 today

Market cap
$2.65B
Beta
0.75
P/E (TTM)
-22.0
EPS (TTM)
-$1.86
52W Low $9.43High $45.85

Volume 0.73M

Average 0.65M

Income Statement

Follow revenue through to earnings.

Revenue

$0.00

FY 2025 · Annual

Operating Income

-$98.06M

FY 2025 · Annual

Net Income

-$86.97M

FY 2025 · Annual

Income Statement

USD
Metric
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue0000
Cost of Revenue000248K
Gross Profit000(248K)
Gross Margin————
Research & Development21.4M28.53M57.42M79.16M
Selling, General & Admin3.76M6.78M10.78M18.9M
Operating Expenses25.16M35.31M68.19M98.06M
Depreciation & Amortization56K157K244K248K
EBITDA(25.71M)(32.41M)(61.68M)(86.72M)
EBITDA Margin————
Operating Income(25.16M)(35.31M)(68.19M)(98.06M)
Operating Margin————
Interest Income372K2.75M6.27M11.08M
Interest Expense374K000
Other Income / Expenses(974K)2.75M6.27M11.08M
Income Before Tax(26.14M)(32.56M)(61.92M)(86.97M)
Pre-Tax Margin————
Income Tax Expense0000
Net Income(26.14M)(32.56M)(61.92M)(86.97M)
Net Margin————
EPS (Basic)(0.82)(1.02)(1.85)(2.38)
EPS (Diluted)(0.82)(1.02)(1.85)(2.38)
Weighted Avg Shares31.85M31.85M33.39M36.51M
Weighted Avg Shares (Diluted)31.85M31.85M33.39M36.51M

MBX Earnings Waterfall · TTM

NASDAQ:MBX · Revenue to Net Income

Key Ratios

EPS$-3.06
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-15.0
P/S Ratio0.0

Analysis

$0 of revenue converted into -$145.1M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-3.06, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipNov 12, 2026
S-8S-8 filingNov 10, 2026
8-KCurrent reportNov 9, 2026
10-QQuarterly reportNov 9, 2026
4Statement of changes in beneficial ownershipNov 5, 2026

How much revenue does MBX generate?

MBX Biosciences, Inc. Common Stock (MBX) reported $0.00 of revenue in fiscal 2025.

Is MBX profitable?

MBX Biosciences, Inc. Common Stock (MBX) reported -$86.97M of net income.